Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Medical | 2 | 2020 | 384 | 1.010 |
Why?
|
| Vena Cava Filters | 7 | 2020 | 96 | 1.000 |
Why?
|
| Vena Cava, Inferior | 7 | 2020 | 143 | 0.910 |
Why?
|
| Career Choice | 2 | 2020 | 139 | 0.790 |
Why?
|
| Device Removal | 6 | 2020 | 161 | 0.710 |
Why?
|
| Medicine | 1 | 2020 | 89 | 0.700 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2022 | 383 | 0.590 |
Why?
|
| Embolization, Therapeutic | 4 | 2021 | 238 | 0.570 |
Why?
|
| Liver Neoplasms | 4 | 2022 | 735 | 0.510 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 508 | 0.500 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 636 | 0.480 |
Why?
|
| Prosthesis Implantation | 3 | 2020 | 125 | 0.460 |
Why?
|
| Radiology, Interventional | 3 | 2021 | 68 | 0.410 |
Why?
|
| Renal Dialysis | 3 | 2021 | 355 | 0.370 |
Why?
|
| Radiography, Interventional | 5 | 2020 | 150 | 0.370 |
Why?
|
| Arteriovenous Fistula | 2 | 2021 | 52 | 0.360 |
Why?
|
| Catheter Ablation | 2 | 2022 | 233 | 0.350 |
Why?
|
| Pulmonary Embolism | 3 | 2020 | 221 | 0.350 |
Why?
|
| Angioplasty | 2 | 2019 | 70 | 0.280 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 229 | 0.270 |
Why?
|
| Angiography | 3 | 2021 | 208 | 0.270 |
Why?
|
| Computed Tomography Angiography | 3 | 2021 | 131 | 0.250 |
Why?
|
| Yttrium Radioisotopes | 2 | 2021 | 46 | 0.240 |
Why?
|
| Treatment Outcome | 13 | 2022 | 7988 | 0.210 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2022 | 36 | 0.210 |
Why?
|
| Workload | 2 | 2020 | 128 | 0.210 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2501 | 0.200 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2021 | 9 | 0.200 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2021 | 15 | 0.200 |
Why?
|
| Brachiocephalic Veins | 1 | 2021 | 33 | 0.200 |
Why?
|
| Hospital Units | 1 | 2020 | 30 | 0.190 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 58 | 0.190 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 27 | 0.190 |
Why?
|
| Hepatic Artery | 1 | 2021 | 83 | 0.190 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 29 | 0.190 |
Why?
|
| Aneurysm, False | 1 | 2020 | 54 | 0.190 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 53 | 0.180 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 76 | 0.180 |
Why?
|
| Brachytherapy | 1 | 2021 | 119 | 0.180 |
Why?
|
| Work-Life Balance | 1 | 2019 | 6 | 0.180 |
Why?
|
| Humans | 24 | 2022 | 86601 | 0.170 |
Why?
|
| Sexism | 1 | 2019 | 51 | 0.170 |
Why?
|
| Social Media | 1 | 2020 | 79 | 0.170 |
Why?
|
| Mentors | 1 | 2019 | 76 | 0.160 |
Why?
|
| Female | 14 | 2021 | 44507 | 0.160 |
Why?
|
| Hemodynamics | 1 | 2021 | 710 | 0.160 |
Why?
|
| Medicare | 1 | 2021 | 406 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2019 | 268 | 0.150 |
Why?
|
| Motivation | 1 | 2020 | 287 | 0.150 |
Why?
|
| Male | 12 | 2021 | 40956 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2021 | 1078 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2020 | 572 | 0.140 |
Why?
|
| Sex Factors | 1 | 2019 | 1054 | 0.140 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.140 |
Why?
|
| Stents | 2 | 2020 | 377 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 469 | 0.130 |
Why?
|
| Prosthesis Design | 4 | 2019 | 278 | 0.130 |
Why?
|
| Retrospective Studies | 9 | 2022 | 8475 | 0.130 |
Why?
|
| Prosthesis Failure | 1 | 2014 | 111 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2015 | 2207 | 0.120 |
Why?
|
| Catheters, Indwelling | 2 | 2013 | 110 | 0.110 |
Why?
|
| Catheterization, Central Venous | 2 | 2013 | 116 | 0.110 |
Why?
|
| Endoleak | 1 | 2012 | 35 | 0.110 |
Why?
|
| Middle Aged | 10 | 2021 | 25017 | 0.100 |
Why?
|
| Hemostatics | 1 | 2012 | 56 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 112 | 0.100 |
Why?
|
| Aged | 9 | 2021 | 18402 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 243 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 6501 | 0.090 |
Why?
|
| Time Factors | 4 | 2020 | 5209 | 0.080 |
Why?
|
| Chicago | 3 | 2019 | 1379 | 0.080 |
Why?
|
| Fluoroscopy | 2 | 2020 | 119 | 0.080 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 731 | 0.080 |
Why?
|
| Young Adult | 4 | 2021 | 5974 | 0.080 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 213 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2013 | 1267 | 0.060 |
Why?
|
| Phlebography | 2 | 2016 | 66 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2009 | 509 | 0.060 |
Why?
|
| Adult | 6 | 2021 | 25640 | 0.060 |
Why?
|
| Risk Factors | 3 | 2019 | 5416 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 136 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 8979 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2021 | 49 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2021 | 36 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3636 | 0.050 |
Why?
|
| Microwaves | 1 | 2021 | 34 | 0.050 |
Why?
|
| Retreatment | 1 | 2021 | 107 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 197 | 0.050 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 15 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 58 | 0.050 |
Why?
|
| Workflow | 1 | 2020 | 77 | 0.050 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 95 | 0.050 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 37 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 70 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 24 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2020 | 116 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 1990 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 149 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 227 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2020 | 158 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2019 | 114 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 134 | 0.040 |
Why?
|
| Aspirin | 1 | 2019 | 156 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 220 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2600 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2705 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 579 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 243 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 1139 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 864 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2020 | 408 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1313 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1801 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 154 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1749 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 70 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 1860 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1576 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2009 | 121 | 0.020 |
Why?
|
| United States | 1 | 2021 | 6665 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2261 | 0.020 |
Why?
|